
The top 5 OncLive TV videos of the week cover insights in HER2+ breast cancer, NSCLC, ovarian cancer, prostate cancer, and sarcoma.
During a recent OncLive® State of the Science Summit™ on gynecologic oncology held on November 4, 2026, in Chicago, Illinois, chaired by Katherine Kurnit, MD, MPH, of the University of Chicago Medicine, faculty discussed ovarian cancer topics including current and emerging therapies in low-grade serous ovarian cancer, optimal treatment selection for PARP inhibitors, and antibody-drug conjugates as novel therapeutic strategies.






